BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 23050139)

  • 21. MIBG in neuroblastoma diagnosis and treatment.
    Olecki E; Grant CN
    Semin Pediatr Surg; 2019 Dec; 28(6):150859. PubMed ID: 31931960
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aurora Kinase A inhibition enhances DNA damage and tumor cell death with
    Kumar P; Koach J; Nekritz E; Mukherjee S; Braun BS; DuBois SG; Nasholm N; Haas-Kogan D; Matthay KK; Weiss WA; Gustafson C; Seo Y
    EJNMMI Res; 2024 Jun; 14(1):54. PubMed ID: 38869684
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Feasibility, toxicity and response of upfront metaiodobenzylguanidine therapy therapy followed by German Pediatric Oncology Group Neuroblastoma 2004 protocol in newly diagnosed stage 4 neuroblastoma patients.
    Kraal KC; Bleeker GM; van Eck-Smit BL; van Eijkelenburg NK; Berthold F; van Noesel MM; Caron HN; Tytgat GA
    Eur J Cancer; 2017 May; 76():188-196. PubMed ID: 28329731
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical Significance of Pretreatment FDG PET/CT in MIBG-Avid Pediatric Neuroblastoma.
    Kang SY; Rahim MK; Kim YI; Cheon GJ; Kang HJ; Shin HY; Kang KW; Chung JK; Kim EE; Lee DS
    Nucl Med Mol Imaging; 2017 Jun; 51(2):154-160. PubMed ID: 28559940
    [TBL] [Abstract][Full Text] [Related]  

  • 25. I-131 MIBG post-therapy scan is more sensitive than I-123 MIBG pretherapy scan in the evaluation of metastatic neuroblastoma.
    Yang J; Codreanu I; Servaes S; Zhuang H
    Nucl Med Commun; 2012 Nov; 33(11):1134-7. PubMed ID: 22825037
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of semi-quantitative scoring system for metaiodobenzylguanidine (mIBG) scans in patients with relapsed neuroblastoma.
    Messina JA; Cheng SC; Franc BL; Charron M; Shulkin B; To B; Maris JM; Yanik G; Hawkins RA; Matthay KK
    Pediatr Blood Cancer; 2006 Dec; 47(7):865-74. PubMed ID: 16444675
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of a real-time polymerase chain reaction assay for prediction of the uptake of meta-[(131)I]iodobenzylguanidine by neuroblastoma tumors.
    Carlin S; Mairs RJ; McCluskey AG; Tweddle DA; Sprigg A; Estlin C; Board J; George RE; Ellershaw C; Pearson AD; Lunec J; Montaldo PG; Ponzoni M; van Eck-Smit BL; Hoefnagel CA; van den Brug MD; Tytgat GA; Caron HN
    Clin Cancer Res; 2003 Aug; 9(9):3338-44. PubMed ID: 12960120
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selective serotonin reuptake inhibitors (SSRIs) prevent meta-iodobenzylguanidine (MIBG) uptake in platelets without affecting neuroblastoma tumor uptake.
    Blom T; Meinsma R; Rutgers M; Buitenhuis C; Dekken-Van den Burg M; van Kuilenburg ABP; Tytgat GAM
    EJNMMI Res; 2020 Jul; 10(1):78. PubMed ID: 32642907
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thrombocytopenia after meta-iodobenzylguanidine (MIBG) therapy in neuroblastoma patients may be caused by selective MIBG uptake via the serotonin transporter located on megakaryocytes.
    Blom T; Meinsma R; di Summa F; van den Akker E; van Kuilenburg ABP; Hansen M; Tytgat GAM
    EJNMMI Res; 2021 Aug; 11(1):81. PubMed ID: 34424429
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reverse transcriptase-polymerase chain reaction (RT-PCR) analysis of monoamine transporters in neuroblastoma cell lines: correlations to meta-iodobenzylguanidine (MIBG) uptake and tyrosine hydroxylase gene expression.
    Lode HN; Bruchelt G; Seitz G; Gebhardt S; Gekeler V; Niethammer D; Beck J
    Eur J Cancer; 1995; 31A(4):586-90. PubMed ID: 7576974
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pinhole imaging of 131I-metaiodobenzylguanidine (131I-MIBG) in an animal model of neuroblastoma.
    Accorsi R; Morowitz MJ; Charron M; Maris JM
    Pediatr Radiol; 2003 Oct; 33(10):688-92. PubMed ID: 12908090
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Iodine-131 metaiodobenzylguanidine therapy for neuroblastoma: reports so far and future perspective.
    Kayano D; Kinuya S
    ScientificWorldJournal; 2015; 2015():189135. PubMed ID: 25874239
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regional alterations of myocardial norepinephrine transporter density in streptozotocin-induced diabetic rats: implications for heterogeneous cardiac accumulation of MIBG in diabetes.
    Kiyono Y; Iida Y; Kawashima H; Tamaki N; Nishimura H; Saji H
    Eur J Nucl Med; 2001 Jul; 28(7):894-9. PubMed ID: 11504086
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improved selectivity of mIBG uptake into neuroblastoma cells in vitro and in vivo by inhibition of organic cation transporter 3 uptake using clinically approved corticosteroids.
    Bayer M; Schmitt J; Dittmann H; Handgretinger R; Bruchelt G; Sauter AW
    Nucl Med Biol; 2016 Sep; 43(9):543-551. PubMed ID: 27376201
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Computer-assisted Curie scoring for metaiodobenzylguanidine (MIBG) scans in patients with neuroblastoma.
    Sokol EA; Engelmann R; Kang W; Pinto N; Starkey A; Lai H; Nadel H; Shulkin BL; Pu Y; Appelbaum D; Yanik GA; Cohn SL; Armato SG; Volchenboum S
    Pediatr Blood Cancer; 2018 Dec; 65(12):e27417. PubMed ID: 30198643
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phase I Study of Vorinostat as a Radiation Sensitizer with 131I-Metaiodobenzylguanidine (131I-MIBG) for Patients with Relapsed or Refractory Neuroblastoma.
    DuBois SG; Groshen S; Park JR; Haas-Kogan DA; Yang X; Geier E; Chen E; Giacomini K; Weiss B; Cohn SL; Granger MM; Yanik GA; Hawkins R; Courtier J; Jackson H; Goodarzian F; Shimada H; Czarnecki S; Tsao-Wei D; Villablanca JG; Marachelian A; Matthay KK
    Clin Cancer Res; 2015 Jun; 21(12):2715-21. PubMed ID: 25695691
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activity of iodine-123 metaiodobenzylguanidine in childhood neuroblastoma: lack of relation to tumour differentiation in vivo.
    Brans B; Laureys G; Schelfhout V; Wiele CV; Potter CR; Dhooge C; Simons M; Dierckx RA
    Eur J Nucl Med; 1998 Feb; 25(2):144-9. PubMed ID: 9473262
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dose escalation study of no-carrier-added 131I-metaiodobenzylguanidine for relapsed or refractory neuroblastoma: new approaches to neuroblastoma therapy consortium trial.
    Matthay KK; Weiss B; Villablanca JG; Maris JM; Yanik GA; Dubois SG; Stubbs J; Groshen S; Tsao-Wei D; Hawkins R; Jackson H; Goodarzian F; Daldrup-Link H; Panigrahy A; Towbin A; Shimada H; Barrett J; Lafrance N; Babich J
    J Nucl Med; 2012 Jul; 53(7):1155-63. PubMed ID: 22700000
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TrkA expression in peripheral neuroblastic tumors: prognostic significance and biological relevance.
    Shimada H; Nakagawa A; Peters J; Wang H; Wakamatsu PK; Lukens JN; Matthay KK; Siegel SE; Seeger RC
    Cancer; 2004 Oct; 101(8):1873-81. PubMed ID: 15386308
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor dosimetry using [124I]m-iodobenzylguanidine microPET/CT for [131I]m-iodobenzylguanidine treatment of neuroblastoma in a murine xenograft model.
    Seo Y; Gustafson WC; Dannoon SF; Nekritz EA; Lee CL; Murphy ST; VanBrocklin HF; Hernandez-Pampaloni M; Haas-Kogan DA; Weiss WA; Matthay KK
    Mol Imaging Biol; 2012 Dec; 14(6):735-42. PubMed ID: 22382618
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.